Topics
Cardiovascular diseases
Emergency department presentations during the COVID‐19 pandemic in Queensland (to June 2021): interrupted time series analysis
Restrictions should be accompanied by advice about appropriate locations for seeking medical care, by condition severity and type
Amy L Sweeny · Gerben Keijzers · Andrea Marshall · Emma J Hall · Jamie Ranse · Ping Zhang · Gary Grant · Ya‐Ling Huang · Dinesh Palipana · Yang D Teng · Benjamin Gerhardy · Jaimi H Greenslade · Philip Jones · Julia L Crilly
Increasing screening for atrial fibrillation in general practice: the Atrial Fibrillation Self‐Screening, Management And guideline‐Recommended Therapy (AF Self‐SMART) study
AF self-screening in general practice waiting rooms is feasible, and could reduce the number of AF-related strokes
Katrina Giskes · Nicole Lowres · Jessica Orchard · JiaLin Li · Kirsty McKenzie · Charlotte Mary Hespe · Ben Freedman
Native valve infective endocarditis: a rare complication of rat bite fever caused by Streptobacillus moniliformis
A 44-year-old man presented to the emergency department with left knee monoarthritis
Caitlin Paul · Joseph O'Brien · Sarah Huffam · Daryl Ridley
The long term implications of fertility therapy for the health of women
Cardiovascular disease mortality is not increased in women undergoing IVF, but vigilant surveillance is nonetheless required
Robert J Norman
Long term all‐cause and cardiovascular disease mortality among women who undergo fertility treatment
Reassuringly, fertility treatment does not increase long term all-cause or CVD mortality risk
Stephanie R Yiallourou · Dianna Magliano · Tilahun N Haregu · Melinda J Carrington · Daniel L Rolnik · Luk Rombauts · Andre Rodrigues · Jocasta Ball · Fiona J Bruinsma · Fabricio Da Silva Costa
Systemic amyloidosis in a patient presenting with myopathy, peripheral oedema and proteinuria
A 58-year-old man presented with 4–6 weeks of lower limb muscle weakness, an elevated serum creatine kinase level of 344 U/L, painful paraesthesia, and weight loss
Laura Bywater · Anthea C Gist · Rahul G Muthalaly · Joanna Loh · Ian Simpson · Anthony J White · Andy KH Lim
Ambulance ramping and patients with cardiac‐type symptoms: understanding the unloading queue
Prioritisation for unloading, once obvious cardiac emergencies have been excluded, disadvantages women and older people
Gao Jing Ong · John D Horowitz
Differences in the pre‐hospital management of women and men with stroke by emergency medical services in New South Wales
Refining the assessment of symptoms in women in pre-hospital emergency services care could improve patient outcomes
Xia Wang · Cheryl Carcel · Benjumin Hsu · Sultana Shajahan · Matthew Miller · Sanne Peters · Deborah A Randall · Alys Havard · Julie Redfern · Craig S Anderson · Louisa Jorm · Mark Woodward
Consensus statement on the current pharmacological prevention and management of heart failure
New recommendations for the pharmacological management of heart failure
Andrew P Sindone · Carmine De Pasquale · John Amerena · Christine Burdeniuk · Alicia Chan · Andrew Coats · David L Hare · Peter Macdonald · Aaron Sverdlov · John J Atherton
Sodium–glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?
SGLT2 inhibitors show promise in improving metabolic and cardiovascular health in type 1 diabetes, yet ideal candidates for therapy require careful selection
Jennifer R Snaith · Jerry R Greenfield
The influence of ambulance offload time on 30‐day risks of death and re‐presentation for patients with chest pain
Longer ambulance offload times are associated with greater 30-day risks of death and ambulance re-attendance
Luke P Dawson · Emily Andrew · Michael Stephenson · Ziad Nehme · Jason Bloom · Shelley Cox · David Anderson · Jeffrey Lefkovits · Andrew J Taylor · David Kaye · Karen Smith · Dion Stub
Low risk chest pain? Make the negative a positive
Emergency department presentations are opportunities to discuss cardiovascular risk factors while the patient’s awareness of their importance is heightened
Christopher Zeitz · Angus Baumann
Ulcerative colitis and acute perimyocarditis
A 32-year-old man with 15 years of intermittent bloody diarrhoea was diagnosed with ulcerative proctosigmoiditis
Kenneth K Cho · Yanna Ko · Kelly Nilsen · Christine Verdon · Giuseppe Femia
Value of single troponin values in the emergency department for excluding acute myocardial infarction in Aboriginal and Torres Strait Islander people
Aboriginal and Torres Strait Islander people may benefit from culturally appropriate cardiac risk factor management
Jaimi H Greenslade · Sara Berndt · Laura Stephensen · Katrina Starmer · Greg Starmer · William Parsonage · Victor Lau · Tileah Drahm‐Butler · Tania Davis · Virginia Campbell · Richard Stone · Robert Bonnin · Sarah Ashover · Tanya Milburn · Elizabeth Mowatt · Karlie Proctor · Anthony Brazzale · Louise Ann Cullen
Poor achievement of lipid targets after acute coronary syndrome: what can we improve?
Overcoming problems that impede the delivery of evidence-based care is needed to bridge gaps between science and improving health
Sher May Ng · Jiliu Pan · Ajay K Gupta
Uncontrolled blood pressure in Australia: a call to action
To the Editor: We congratulate Schutte and colleagues1 for their call to action for improved management of blood pressure in Australia, highlighting that 68% of people have uncontrolled high blood pressure. The burden of high blood pressure is unevenly distributed, with Aboriginal and Torres Strait Islander (hereafter referred to respectfully as Indigenous) people reportedly having a higher rate of high blood pressure than non‐Indigenous Australians in every age group.2 Reducing the prevalence of high blood pressure is one of the most important means of reducing serious circulatory diseases, which are among the leading causes of death for Indigenous Australians.3 Hence, we want to extend the call to action and report on what is happening in primary health care settings with the control of blood pressure for Indigenous people. During 2012–13, we analysed blood pressure screening and follow‐up for patients diagnosed with hypertension (n = 6523) from 123 primary health care centres across Australia using continuous quality improvement data from audits of adherence to best practice chronic illness care.4 Given there are no recently available data on follow‐up actions after an abnormal blood pressure reading at this geographic scale, and as blood pressure continues to be relatively uncontrolled, these data continue to provide unique insight. The data, aggregated at primary health care centre level (Box), tells a story of clinical inertia. Regular blood pressure screening was done well — centres on average completed blood pressure screening for about 90% of patients within the past 6 and 12 months. In this cohort, about 65% of patients recorded abnormal blood pressure (n = 4240). Most primary health care centres had documentation of a follow‐up plan for more than 70% of patients, but there was wide variation (range, 0–100%; Box). Dealing with the low levels of medication reviews and adjustments (mean, ~15%; range, 0–100%) is a vital early step in limiting the contribution of uncontrolled blood pressure to adverse health outcomes for Indigenous people. These data support the need for training on strategies to overcome clinical inertia, which was identified as a top priority by over 200 Indigenous primary health care practitioners, managers and policymakers.5 We add to the call for more attention on prevention of cardiovascular disease and suggest additional investment in evidence‐based interventions appropriate to Indigenous Australian culture and needs. The time for system‐wide action has come. Box – Boxplots showing a record of scheduled services received by patients with hypertension and follow‐up of abnormal findings within the last 12 months of audit (unless otherwise indicated) at primary health centres during 2012–13 x = mean value. More information on how to interpret box plots is available in Matthews et al.4
Jodie Bailie · Veronica Matthews · Ross S Bailie
Uncontrolled blood pressure in Australia: a call to action
In reply
Aletta E Schutte · Garry Jennings · Markus Schlaich
Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease
Colchicine is an inexpensive new treatment for coronary heart disease that is both safe and effective in select patients
Stefan M Nidorf · Jamie Layland · Philip C Robinson · Sanjay Patel · Peter J Psaltis · Peter L Thompson
Plasma aldosterone to renin ratio for the detection of primary aldosteronism in patients with drug‐resistant hypertension
A 55-year-old man was referred for management of resistant hypertension
Kay W Choy · Renata Libianto · Ian Simpson · Jun Yang
If you look for primary aldosteronism, you find it
A condition considered rare is not sought; a condition not sought is not diagnosed; a condition not diagnosed is considered rare…
Mark R Nelson
Doctors with borders: the impact of international border closures on Timorese people who need cardiac procedures
The COVID-19 border closures delayed cardiac interventions for young patients by at least 18 months
Elizabeth Paratz · Joaquina Maurays · Ricardo Flavio · Alan Appelbe · Noel Bayley
Common conditions that mimic asthma
Asthma is one of the most common chronic diseases in Australia, affecting 11% of the population
Helen K Reddel
Abdominal discomfort leading to the incidental finding of complete heart block
A 62-year-old man presented complaining of 3 days of abdominal discomfort on a background of a month-long history of fatigue and fevers
Angus AW Baumann · Nicholas J Montarello · Glenn D Young
Detecting primary aldosteronism in Australian primary care: a prospective study
GPs actively screening for primary aldosteronism could facilitate early treatment of this readily managed form of secondary hypertension
Renata Libianto · Grant M Russell · Michael Stowasser · Stella M Gwini · Peta Nuttall · Jimmy Shen · Morag J Young · Peter J Fuller · Jun Yang
Achieving lipid targets within 12 months of an acute coronary syndrome: an observational analysis
Optimising lipid control could include more intensive therapy and combinations of medications, including novel agents
Noor Alsadat · Karice Hyun · Farzaneh Boroumand · Craig Juergens · Leonard Kritharides · David B Brieger